全文获取类型
收费全文 | 37493篇 |
免费 | 2031篇 |
国内免费 | 224篇 |
专业分类
耳鼻咽喉 | 499篇 |
儿科学 | 733篇 |
妇产科学 | 811篇 |
基础医学 | 5050篇 |
口腔科学 | 1622篇 |
临床医学 | 2874篇 |
内科学 | 8100篇 |
皮肤病学 | 1100篇 |
神经病学 | 3811篇 |
特种医学 | 1756篇 |
外科学 | 6435篇 |
综合类 | 187篇 |
一般理论 | 8篇 |
预防医学 | 1762篇 |
眼科学 | 427篇 |
药学 | 2168篇 |
中国医学 | 113篇 |
肿瘤学 | 2292篇 |
出版年
2024年 | 22篇 |
2023年 | 308篇 |
2022年 | 652篇 |
2021年 | 1136篇 |
2020年 | 759篇 |
2019年 | 955篇 |
2018年 | 1150篇 |
2017年 | 850篇 |
2016年 | 979篇 |
2015年 | 1230篇 |
2014年 | 1591篇 |
2013年 | 1852篇 |
2012年 | 2926篇 |
2011年 | 3124篇 |
2010年 | 1899篇 |
2009年 | 1681篇 |
2008年 | 2662篇 |
2007年 | 2624篇 |
2006年 | 2483篇 |
2005年 | 2400篇 |
2004年 | 2016篇 |
2003年 | 1817篇 |
2002年 | 1692篇 |
2001年 | 284篇 |
2000年 | 216篇 |
1999年 | 278篇 |
1998年 | 290篇 |
1997年 | 297篇 |
1996年 | 196篇 |
1995年 | 185篇 |
1994年 | 145篇 |
1993年 | 125篇 |
1992年 | 101篇 |
1991年 | 92篇 |
1990年 | 76篇 |
1989年 | 65篇 |
1988年 | 72篇 |
1987年 | 53篇 |
1986年 | 53篇 |
1985年 | 32篇 |
1984年 | 43篇 |
1983年 | 35篇 |
1982年 | 37篇 |
1981年 | 30篇 |
1980年 | 30篇 |
1979年 | 18篇 |
1978年 | 18篇 |
1977年 | 15篇 |
1975年 | 18篇 |
1974年 | 16篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
5.
6.
Mariela Dutra Gontijo Moura Soraya de Mattos Camargo Grossmann Linaena Méricy da Silva Fonseca Maria Inês Barreiros Senna Ricardo Alves Mesquita 《Journal of oral pathology & medicine》2006,35(6):321-326
BACKGROUND: Oral hairy leukoplakia (OHL) may be an indicator of the progression of Human Immunodeficiency Virus (HIV)-induced immuno-depression, and the evaluation of risk factors leading to OHL is important in the management of these HIV-infected patients. However, there are few studies that analyze risk factors leading to OHL in the Brazilian population. The aim of this case-control study is to present data about prevalence rates and risk factors leading to OHL in a sample of HIV-infected adults in Brazil. METHODS: This case-control study included 111 HIV-infected patients treated at a clinic for sexually transmitted diseases and HIV. In the initial examinations with dentists, variables were collected from all patients. Diagnosis of OHL was performed in accordance with the International Classification System and cytological features. The Fisher and the chi-squared tests were used for statistical analysis. The proportional prevalence and odds ratio were estimated. RESULTS: Outcome presented a positive, statistically significant association among the presence of OHL and viral load of 3000 copies/mul or greater (P = 0.0001; odds ratio (OR) = 5.8), presence of oral candidiasis (P = 0.0000; OR = 11.1), previous use of fluconazole (P = 0.0000; OR = 24.6), and use of systemic acyclovir (P = 0.032; OR = 4.3). Antiretroviral medication presented a negative, statistically significant association with the presence of OHL (P = 0.002; OR = 8.4). CONCLUSIONS: Prevalence of OHL was 28.8%. Viral load, oral candidiasis, previous use of fluconazole, and systemic acyclovir were determined to be risk factors for OHL. Antiretroviral medication proved to be protective against the development of OHL. 相似文献
7.
8.
Federigo Sicuteri Maria Nicolodi Bruno Marcello Fusco Salvatore Orlando 《Headache》1991,31(9):577-581
Following tooth pulp extirpation, some subjects suffer from persistent pain which affects edentate sites in absence of any local pathology. As regards this peculiar pain, called phantom tooth pain (PTP), what is puzzling is the fact there is a low prevalence of PTP in a very large population showing identical conditions of tooth pulp extirpation. The present investigation indicates that PTP mainly affects migraine (M) and cluster headache (CH) sufferers, whereas it does not affect subjects who have a negative personal and family history for idiopathic headache (IH). These results circumscribe the presence of PTP to a specific section of the population. The present results, besides indicating that PTP may be the result of a peculiar neuronal predisposition relating to IH pathogenesis, suggests some practical therapeutic hints. In fact, successful anti- M and anti-CH prophylactic treatment greatly improve PTP syndrome. 相似文献
9.
Patients with Fabry disease on dialysis in the United States. 总被引:9,自引:0,他引:9
Ravi Thadhani Myles Wolf Michael L West Marcello Tonelli Robin Ruthazer Gregory M Pastores Gregorio T Obrador 《Kidney international》2002,61(1):249-255
BACKGROUND.: Fabry disease results from an X-linked deficiency of lysosomal alpha-galactosidase A and is a rare cause of end-stage renal disease. Little is known about the characteristics of patients with Fabry disease that initiate dialysis in the United States, although data from Europe suggests these individuals have a poor survival. METHODS.: Using the United States Renal Disease System database, we first studied in detail 42 Fabry patients who initiated dialysis between April 1995 (following the introduction of the new detailed HCFA 2728 form) and July 1998. To examine crude survival in a larger cohort, 95 Fabry patients were studied who initiated dialysis between 1985 and 1993, similar to the European Registry. Diabetic and non-diabetic controls matched by age, gender, race, year of dialysis initiation, and initial dialysis modality were examined for comparison. RESULTS.: During the years 1995 to 1998, the mean age of Fabry patients that initiated dialysis was 42 years, 83% were Caucasian, and 10% were African American. Despite the X-linked inheritance of Fabry disease, 12% of Fabry patients on dialysis were female. At initiation of dialysis mean serum albumin and creatinine were significantly higher and mean body mass index was significantly lower among Fabry patients, but mean glomerular filtration rate was similar to controls. Fabry patients tended to have a lower three-year survival compared to non-diabetic controls, but the results were not significantly different. In a larger cohort of Fabry patients who initiated dialysis between 1985 and 1993, the three-year survival of Fabry patients was significantly lower than non-diabetic controls: 63% (95% CI, 50 to 75%) versus 74% (95% CI, 67 to 80%; P=0.03). CONCLUSION.: End-stage renal disease is associated with significant morbidity and mortality among patients with Fabry disease. Recent evidence that progression of Fabry disease may be attenuated by enzyme replacement therapy necessitates increased awareness of Fabry disease and its comorbidities. 相似文献
10.